Emergent BioSolutions Inc. (EBS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Emergent BioSolutions Inc...

    NYSE: EBS · Real-Time Price · USD
    9.14
    -0.05 (-0.54%)
    At close: Oct 03, 2025, 3:59 PM
    9.32
    1.97%
    Pre-market: Oct 06, 2025, 08:32 AM EDT

    Emergent BioSolutions Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.66 -0.16 -2.64 10.60
    PEG Ratio
    		 0.04 -0.00 0.01 -0.36
    PS Ratio
    		 0.50 0.12 0.53 1.30
    PB Ratio
    		 1.05 0.19 0.43 1.44
    P/FCF Ratio
    		 14.15 -0.48 -3.95 24.20
    P/OCF Ratio
    		 8.63 -0.6 -17.35 7.24
    OCF/S Ratio
    		 0.06 -0.2 -0.03 0.18
    Debt / Equity Ratio
    		 1.37 1.32 1.02 0.52
    Quick Ratio
    		 1.77 0.54 0.70 2.46
    Current Ratio
    		 3.69 1.04 0.98 3.40
    Asset Turnover
    		 0.73 0.58 0.35 0.61
    Interest Coverage
    		 -1.53 -8.26 -4.45 10.22
    Return on Equity
    		 -0.39 -1.17 -0.16 0.14
    Return on Assets
    		 -0.14 -0.42 -0.07 0.07
    Return on Invested Capital
    		 -0.12 -0.48 -0.06 0.10
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.30 0.33 0.38 0.58
    Net Profit Margin
    		 -0.19 -0.72 -0.2 0.12
    Pretax Profit Margin
    		 -0.14 -0.7 -0.2 0.18
    Operating Profit Margin
    		 -0.11 -0.69 -0.15 0.20
    FCF Margin
    		 0.04 -0.25 -0.13 0.05
    EBITDA Margin
    		 0.04 -0.48 -0.03 0.26

    Add to Watchlist